https://www.pro.novartis.com/ch-de/ 2026-03-09T13:33:44+00:00 daily 1.0 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie/herausforderungen-der-behandlung 2025-10-30T13:21:22+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie/was-ist-atherosklerose 2025-10-30T13:09:10+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie/zusammenhang-ascvd-ldl-c 2026-02-13T13:41:06+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie/diagnose-risikofaktoren 2026-02-13T13:44:03+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie/behandlung-von-atherosklerose 2025-10-30T13:21:55+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/herz-niere-stoffwechsel/hypercholesterinaemie 2025-10-30T11:06:24+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/pathophysiologie 2026-02-19T15:34:27+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie 2026-04-01T13:23:19+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/ursache-und-epidemiologie-von-brustkrebs 2026-02-13T15:19:39+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/brustkrebs-diagnose 2026-01-23T18:52:28+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/Klassifikationssysteme-bei-Mammakarzinom 2026-02-26T13:55:41+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/therapieoptionen 2026-02-26T12:45:38+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/therapieoptionen/esmo-leitlinie-zur-behandlung-von 2026-02-26T12:53:18+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/onkologie/nccnr-leitlinie-zur-behandlung-von-brustkrebs 2026-02-26T12:55:11+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/neurologie/multiple-sklerose 2026-03-20T12:34:04+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/neurologie/multiple-sklerose/diagnose-symptome-der-multiplen-sklerose 2026-03-16T12:46:11+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/neurologie/multiple-sklerose/therapie-der-multiplen-sklerose 2026-03-23T13:08:48+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/neurologie/multiple-sklerose/multiple-sklerose-eine-vielschichtige-erkrankung-mit 2026-02-23T10:35:11+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/neurologie/multiple-sklerose/verlaessliche-information-fuer-ms-patienten 2026-03-18T09:55:36+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/kontakt 2026-02-26T15:05:24+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/kontakt/individuelle-beratung 2025-06-17T12:48:14+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/403-page 2025-09-18T11:14:06+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/404-page 2025-05-19T15:50:34+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/nutzungsbedingungen 2025-05-19T09:38:40+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/kontakt/formular-fuer-medizinische-fragen 2025-05-06T13:09:03+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/kontakt-send 2025-05-16T17:30:35+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/herz-niere-stoffwechsel/herzinsuffizienz-eine-unterschaetzte-erkrankung 2026-02-27T12:34:16+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/herz-niere-stoffwechsel/herzinsuffizienz-eine-unterschaetzte-erkrankung/symptome-gesichter-der-herzinsuffizienz 2026-02-27T13:36:41+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/herz-niere-stoffwechsel/herzinsuffizienz-eine-unterschaetzte-erkrankung/die-nyha-klassifizierung-im-ueberblick 2026-01-23T19:11:25+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/herz-niere-stoffwechsel 2026-01-26T16:11:10+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/multiple-sklerose-ms 2026-03-23T13:12:41+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/brustkrebs-eine-vielschichtige-erkrankung 2026-03-23T10:15:22+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie 2026-01-22T10:04:18+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/das-konzept-der-axspa 2026-02-27T13:14:10+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/epidemiologie-und-symptomatik-der-axspA 2026-02-27T13:16:47+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/rheuma-bei-kindern-und-jugendlichen 2026-01-22T10:06:20+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/heterogene-manifestationen-der-psoriasis-arthritis 2026-01-22T10:02:23+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/heterogene-manifestationen-der-psoriasis-arthritis/psoriasis 2026-02-26T15:07:33+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/rheumatologie/heterogene-manifestationen-der-psoriasis-arthritis/diagnose-der 2026-01-22T10:05:01+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/psoriasis-krankheitslast 2026-03-20T16:02:49+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/hidradenitis-suppurativa/psoriasis-krankheitslast/psoriasis-symptome 2026-03-16T09:31:17+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/psoriasis/psoriasis-diagnose 2026-02-02T15:12:57+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/hidradenitis-suppurativa/psoriasis/allgemeine-therapie 2026-03-20T15:50:19+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/hidradenitis-suppurativa 2026-03-02T14:34:33+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/hidradenitis-suppurativa/symptome-und-diagnose-von-hs 2026-03-02T14:47:31+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/dermatologie/chronic-spontaneous-urticaria 2026-02-02T15:13:19+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/leqvio-home 2025-10-16T14:05:50+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/andauernde-rueckenschmerzen-jungen-jahren 2026-01-23T19:17:28+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/therapiegebiete/dermatologie/chronic-spontaneous-urticaria/klassifizierung-und-behandlung-der-urtikaria 2026-03-27T14:38:46+00:00 hourly 0.5 https://www.pro.novartis.com/ch-de/post-aad-highlight-meeting 2025-05-06T15:49:34+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/webshop 2026-02-05T13:50:19+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/herz-niere-stoffwechsel 2026-02-18T14:21:33+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/neurologie/neurotransmitter 2026-01-22T13:15:03+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/rheumatologie-events 2026-02-18T14:44:56+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/dermatologie 2026-02-18T14:34:20+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/dermato-lp 2025-10-14T13:23:32+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/hemato-lp 2025-10-14T09:03:35+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/cardio-lp 2025-05-06T16:42:27+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/neuro-lp 2025-06-05T16:19:54+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/onco-lp 2025-05-06T16:37:05+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/onkologie 2026-03-31T11:14:09+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/haematologie 2026-02-18T14:48:03+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/kongresse/neurologie 2026-02-27T15:04:14+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/produkte 2025-11-28T14:10:51+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/dermatologie 2026-02-27T15:20:12+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/weiterbildungen 2026-03-20T15:42:30+00:00 daily 0.5 https://www.pro.novartis.com/ch-de/sitemap.xml 2026-04-02T01:46:48+00:00